Alzheimer’s drugs ‘make no meaningful difference to patients’, say researchers
London news, sport and culture | The Standard | London Evening …
April 16, 2026
A review, which included licensed drugs lecanemab and donanemab, found the effects were ‘trivial’.
Discussion in the ATmosphere